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The notion that epigenetics may play an important role in the establishment and
maintenance of sex differences in the brain has garnered great enthusiasm but the
reality in terms of actual advances has been slow. Two general approaches include the
comparison of a particular epigenetic mark in males vs. females and the inhibition of key
epigenetic enzymes or co-factors to determine if this eliminates a particular sex difference
in brain or behavior. The majority of emphasis has been on candidate genes such as
steroid receptors. Only recently have more generalized survey type approaches been
achieved and these promise to open new vistas and accelerate discovery of important
roles for DNA methylation, histone modification, genomic imprinting and microRNAs
(miRs). Technical challenges abound and, while not unique to this field, will require novel
thinking and new approaches by behavioral neuroendocrinologists.
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In 2009 a minisymposium was held at the annual meeting of the Society for Neuroscience titled
‘‘Epigenetics of Sex Differences in the Brain’’. Representatives from five laboratories presented
their findings to a standing-room-only audience, indicative of the burgeoning interest in both
epigenetics in the nervous system and the origins and maintenance of sex differences in the brain.
But the interest far out distanced the field. The concluding remarks at the symposium summarized
that what we had just listened to was largely made up of promises, promises of future progress
with very little hard data actually in hand (McCarthy et al., 2009a). Some progress has been made
in the intervening 5 plus years, but given the general rate at which research moves in the modern
era, the progress is surprisingly little. Why would this be? A number of factors can be blamed for
slowing the pace. First is simply the small number of labs that work on the topic of epigenetics and
sex differences. This may change in the coming years with the implementation of new policies by
the National Institutes of Health requiring equal representation of males and females in preclinical
research (Clayton and Collins, 2014), but then again it may not. Second is the vastness of the
topic. Epigenetics is increasingly a general term that encompasses many and varied specifics. These
include changes to the DNA via methylation, which become more and more complicated the more
we learn, changes to the histones of which there is not quite an infinite variety but something close,
imprinting, a still mysterious process of allelic regulation especially in the brain, and microRNAs
(miRs) which can impact multiple genes simultaneously. Then there are the technical challenges,
not the least of which is the need for bioinformatics expertise to handle the voluminous data
generated when conducting sequencing experiments. Together these factors create a substantial
energy barrier to the pursuit of epigenetic analyses, nonetheless interest in the topic remains high.
Why epigenetics is important to sex differences is embedded in several lines of thought. From a
strictly biological standpoint one could argue that epigenetic regulation provides for the assurance
that gonadal sex and brain sex are coordinated independent of genetic sex, i.e., chromosome
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complement. From an evolutionary standpoint the goal is
procreation and thus an animal’s behavior needs to be
coordinated with gamete production and fertilization, regardless
of genetic constitution. By allowing for epigenetic regulation of
behavior, driven by gonad-derived signals such as steroids, this
coordination can be assured. Moreover, some species exhibit
facultative sex changing and the placing and removing of
epigenetic marks is a simple way to achieve that end. But
epigenetic regulation of sex differences is also important to
influences not considered directly biological, such as experience
or environment in animals and culture and society in humans.
Repeated sex-typic experiences or expectations could feasibly
impact the epigenome in a manner that further enhances or
even canalizes sex differences. Conversely, the malleability of
epigenetics could contribute to discordance between biological
sex and sexually differentiated endpoints such as gender identity
or to naturally occurring variations in partner preference. Thus
understanding the factors that regulate epigenetic changes in
males and females and the impact these changes have on
brain and behavior has wide ranging implications and potential
impacts.
In addition to the variety of possible epigenetic changes noted
above, there is also a need to separate and interpret findings
by developmental state, sex (obviously), brain region and cell
type. When considering brain sex differences all of these are
fundamental, beginning with developmental stage. The principle
drivers of sex differences are steroid hormones, which differ
profoundly in males and females at some times of life and
very little or not at all at other times of life. Early exposure to
steroids has enduring effects and most brain sex differences are
established during a critical developmental window, although the
timing of the window may vary for different endpoints as well
as for masculinization vs. feminization. For steroid-mediated
masculinization of reproductive behavior, the beginning of
the critical window is delineated by the onset of gonadal
steroidogenesis by the testis of the fetal male (around embryonic
day 18 in rats and mice) and the close is the developmental age
at which a female brain is no longer sensitive to exogenously
induced masculinization which is accomplished by steroid
injection (Figure 1). In our rodent models this is about 1 week
after birth. Thus the sensitive period is perinatal, i.e., both prior
to and just after birth. In primates evidence to date suggests the
process of brain sexual differentiation is largely prenatal although
the exact parameters are difficult to firmly establish for the
obvious reasons associated with work in humans and primates.
The interested reader is referred to the following reviews for a
more thorough discussion of the details of sexual differentiation
(Arnold et al., 2003; De Vries, 2004; Morris et al., 2004; Forger,
2006; de Vries and Södersten, 2009; McCarthy et al., 2009b, 2012;
McCarthy and Arnold, 2011; Shen et al., 2015).
During the critical period circulating testosterone is markedly
higher in males and some portion of this gains access to the brain
where it is locally converted into estradiol. Maternal estradiol also
gains access to the fetal circulation but much of it is sequestered
there by the steroid binding globulin alpha-fetoprotein. There is
detectable estradiol in the brains of males and females during
the critical period and it varies substantially across brain region.
FIGURE 1 | Sexual differentiation of brain and behavior. Sex differences
in the brain are established early in development during a critical period.
Feminization of the brain proceeds in the absence of exposure to elevated
gonadal steroids during the critical period and masculinization occurs when
the fetal testis begins production of androgens at the beginning of the critical
period, the end of which is defined by the developmental stage at which
exogenous administration of androgens to females is ineffective at switching
brain development from feminization to masculinization. Gonadal hormones
rise again in adulthood and promote sex differences in behavior by acting on a
neural substrate that was organized differently in males and females. A central
question in behavioral neuroendocrinology has been how early life exposure to
androgens exerts an enduring influence on adult brain and behavior.
Despite this, the variation in levels between males and females
is found only in a few brain regions, mostly the preoptic area
(POA), and this sex difference is small in magnitude and brief
in duration, being nonexistent within hours after birth (Amateau
et al., 2004; Konkle andMcCarthy, 2011). Nonetheless, in rodents
estradiol is the dominant driver of most sex differences in brain
and behavior. Of additional interest, effective masculinization
of female pups with exogenous estradiol injection requires an
enormous dose, ten times that used in a full grown adult to
induce sexual receptivity. This rather bizarre scenario raises some
interesting questions; how does such a small and transient sex
difference in steroid levels have such a profound effect? Why
is it so hard to masculinize females with exogenous steroid?
One possibility is that forces within the genome act to maintain
femaleness and prevent maleness. One of the likely forces would
be at the epigenetic level and this potential is discussed further
below.
There are two general approaches to the study of brain
sex differences and epigenetics. The first is to simply measure
epigenetic marks in males and females and compare them. The
second is to take a known endpoint that is different in males
and females, be it morphological or behavioral, and determine
if manipulating the system, by blocking or stimulating a key
enzyme for instance, disrupts or mimics the formation of the
sex differences (Figure 2). Each approach has proven fruitful
in its own way. Several recent reviews have effectively cataloged
what we currently know and this can be largely summarized as
there are sex differences in multiple brain regions in multiple
epigenetic marks (Nugent et al., 2010; Nugent and McCarthy,
2011; Auger and Auger, 2013; Kigar and Auger, 2013; Matsuda,
2014). One of the major principles emerging in the larger field of
epigenetics is the integral relationship betweenDNAmethylation
and histone modifications (Cheng, 2014). Put simply, any change
in DNA methylation is likely to be accompanied by some
change to the associated histones, and vice versa. But for most
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FIGURE 2 | Two approaches to epigenetics of brain sex differences.
One approach is to simply measure known epigenetic marks such as histone
acetylation or CpG methylation, and/or the enzymes known to regulate the
establishment and maintenance of these marks and ask, are they different in
males and females? A second approach is to disrupt the establishment of
epigenetic marks early in development by inhibiting the associated enzymes or
cofactors such as methyl binding proteins (MBPs) and ask, does this eliminate
sex differences in adult brain and behavior?
investigators analysis is either at the histone or DNA level, unless
the work specifically targets this interaction. Yet there is good
reason to focus on both, as both types of modifications have
been found to either be important for the process of sexual
differentiation or changed in response to sexual differentiation.
Here are some specifics.
Brain Sex Differences in Histone
Modifications
The best studied form of histone modification is acetylation
of lysines on the extruding polyamine tails, mostly H3 but
also H4 and H2A. Additional modifications at some of the
same critical lysines can toggle the impact of the chromatin
between repressive and permissive (Bernstein et al., 2006; Ku
et al., 2013). Individual site changes often don’t operate in
isolation but are instead coordinated with and influenced by
what is happening at neighboring amino acids, and collectively
the changes on the histones at a particular site will ultimately
determine gene expression, a phenomenon referred to as the
‘‘histone code’’ (Strahl and Allis, 2000). Antibodies to specific
histone modifications allow for crude quantification by Western
blot and the use of Chip-Seq is valuable for pulling down
and sequencing stretches of DNA associated with a particular
modification. The former approach was used by Rissman and
colleagues to document a sex difference in the amount of H4
acetylation in the cortex and hippocampus of rat pups (Tsai
et al., 2009). Acetylation and deacetylation are separate reactions
controlled by distinct enzymes, the histone acetyl transferases
(HATs) and the histone deacetylases (HDACs), respectively,
both of which have multiple isoforms from large complex
families (Lau et al., 2000; Wang et al., 2009; Hayakawa and
Nakayama, 2011). Either stimulation or disruption of these
enzymes by pharmacologic or gene silencing techniques have
been found to impact neuroanatomy (Murray et al., 2009) and
sexual differentiation of behavior (Matsuda et al., 2011). In
both cases the investigators have focused on their particular
system, emphasizing one brain region and one endpoint, either
neuroanatomical or behavioral. Inhibiting HDACs with valproic
acid on the day of birth increased H3 acetylation within a
day, demonstrating that deacetylation is a constitutively active
process in this brain region, and this same treatment reduced
the size of the principle nucleus of the bed nucleus of the stria
terminalis (pBNST). This nucleus is normally larger in males
due to greater cell death in this region in females. There was
no change in the size of the nucleus in females (Murray et al.,
2009), which even though it is normally smaller than in males
is nonetheless capable of getting smaller, in fact why didn’t it
disappear all together? Something seems to have prevented that
from occurring. Importantly the effects of valproic acid treatment
were not generalizable to other regions as there was no change
in the size of the suprachiasmatic nucleus (SCN) or a thalamic
nucleus (Murray et al., 2009). One could speculate that there is
a specific gene or gene network that promotes cell survival in
the pBNST of males (or, promotes cell death in females) and that
it is suppressed via increased acetylation following valproic acid
treatment, and hence the cells die, but not all of them, only those
that make the nucleus larger in males than in females. Likewise
this gene must NOT be important to cell survival in females. This
would require there to be two populations of cells in the pBNST,
one that is influenced by steroids to survive and regulated by
histone acetylation, and one that is not. While possible, this
seems unlikely.
Matsuda et al. (2011) took a slightly different approach
and explored the epigenetic regulation of genes already known
to be central to the process of masculinization of sexual
behavior: estrogen receptor (Esr1), or estrogen receptor alpha
(ERα) and Cyp19a or aromatase, the enzyme that converts
testosterone to estradiol. They found that during the sensitive
period for differentiation, HDACs 2 and 4 were more prevalently
bound at the promoters of Esr1 and Cyp19a in males than
females, which presumably leads to greater deacetylation and
higher gene expression. Reduction in HDAC activity with
either pharmacological treatment (trichostatin A) or antisense
oligonucleotides directed against the mRNA for HDACs 2 and
4, impaired behavioral masculinization.
Both studies are important but could be critiqued for telling
us what we largely already knew. What is lacking is exploration
and discovery of new sources of brain regulation. Forger and
colleagues took an important step in this direction with a genome
wide analysis of a single but essential epigenetic mark, H3K4me3,
which is permissive of gene expression (Shen et al., 2015). They
explored the pBNST in combination with the POA in adult mice
and found ∼250 genes in which there was a sex difference in
associated H3K4me3. The genes identified were associated with
synaptic function and while many are not expressed differently
at baseline, this does not negate the importance of epigenetic
regulation as H3K4me3 has been proposed as a component of
bivalent chromatin, meaning it is in a state of readiness for rapid
shifts into expression.
These few studies summarize the current state-of-the
art in chromatin modifications as a component of sexual
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differentiation. Somewhat greater progress has been made in the
arena of changes to the DNA.
Brain Sex Differences in DNA
Modifications
The canonical epigenetic modulation to DNA is addition of a
methyl group to the 5′ carbon of cytosines that are adjacent to
guanines, referred to as mCpG.Methylation of cytosines adjacent
to other nucleotides is emerging as a particularly important
regulator of gene expression in the brain, but is found at very
low levels in the immature brain when sex differences are
established (Lister et al., 2013). Interest in sex differences in
DNA methylation was piqued by the remarkable studies from
the Meaney laboratory demonstrating how early life experience,
in particular the type of maternal care one receives, impacts the
methylation of specific cytosine residues in the promoter of the
gene for the glucocorticoid receptor (GR) in the hippocampus
and that this, in ways not fully understood, contributes to
a transgenerational stability in the intensity of maternal care
shown by females (Champagne, 2008; Curley et al., 2011;
Kundakovic and Champagne, 2015). These studies highlighted
both the importance of steroid receptors and their malleability
at the epigenetic level. Champagne and Curley (2008) furthered
the field by characterizing epigenetic changes in the promoter
of the estrogen receptor (Esr1) in response to hormonal and
environmental cues, but they did not address sex differences nor
the process of sexual differentiation. Toward this end, Auger
and colleagues mapped a region of the Esr1, finding that males
had higher levels of methylation than females in tissue from the
POA. They further found that the higher methylation in males
correlated with reduced ER protein. Moreover, if they stimulated
the maternal grooming that had been shown by Meaney and
Champagne to impact GR methylation, it also altered Esr1
methylation, only in their case they also mimicked the naturally
occurring variation in which the maternal dam grooms her male
pupsmuchmore frequently than her female pups (Edelmann and
Auger, 2011). This behavioral change was determined to underlie
the sex difference, thus nicely demonstrating how experience can
alter the epigenome and how in turn the epigenome can impact
hormone sensitivity of a particular brain region.
Because of the centrality of estradiol to rodent brain sexual
differentiation, both isoforms of the estrogen receptor were
obvious candidate genes for epigenetic modifications. In an
exhaustive study of three brain regions (POA, hypothalamus
and hippocampus), three developmental time points (newborn,
adolescent and adult), three candidate genes (Esr1, Esr2 and PR)
and three groups (males, females and masculinized females) the
amount of methylation within CpG islands of the promoters
of each gene was found to increase across development and
also show transient sex differences, but, none of these changes
were permanent nor were they predictive of expression (Schwarz
et al., 2010). This highlights much of the challenge with studies
of DNA methylation, that the relationship between methylation
status and expression is not necessarily a repressive one and
that methylation status changes in the brain with age. Moreover,
in addition to the methylation itself, DNA methyl binding
proteins (MBPs) are important partners in gene regulation. The
best known of these is MeCP2, a DNA MBP mutated in Rett
Syndrome (Amir et al., 1999). Under normal conditions, MeCP2
is recruited to methylated promoters and further enhances
repression of gene expression. Auger and colleagues have
exploited the ease of quantifying methyl CpG binding protein
2 (MeCP2) and of inhibiting it, to demonstrate important sex
differences and regulation of the sexual differentiation of juvenile
play behavior, a social behavior that is expressed at higher
levels by males and is importantly controlled by the amygdala
(Auger and Olesen, 2009; Auger et al., 2011). Vasopressin is a
neuropeptide expressed at higher levels in the male amygdala
and MeCP2 represses its expression in females. Emancipating
this gene by silencing MeCP2 for even a brief period during
development permanently alters the pattern of expression and
eliminates the sex difference both in vasopressin levels and in
social play behavior (Forbes-Lorman et al., 2012). More recently,
they determined that one of the genes regulated by MeCP2 is
GFAP, an astrocyte-specific structural protein (Forbes-Lorman
et al., 2014), illustrating yet another important point, epigenetics
impacts all cell types, a distinction we often miss in our brain
region homogenates.
The candidate gene approach can be both useful and fruitless,
sometimes telling us what we already know and in other instances
not agreeing with what we think we know. For this reason we also
need discovery based approaches. What is being epigenetically
regulated that we haven’t considered? This type of hypothesis-
free approach has the potential to be enormously powerful, but it
is also enormously challenging. The genome is large but becomes
vastly larger when viewed in the context of DNA methylation.
This is in part because much of the methylation occurs outside of
genes, in intergenic regions, and how that methylation impacts
neural function remains largely unexplored. Add in non-CpG
methylation (Guo et al., 2014) and hydroxymethylation, which
some call the 6th base (Irwin et al., 2014; Feng et al., 2015)
and the complexity level rises still further. Combine this with
the use of bisulfite conversion, which is required to detect CpG
methylation but is a process that can be overdone or underdone,
plus the cost of sequencing, and the energy barrier rises still
higher. Finally, if one does get that far, there is the issue of
bioinformatics analyses and it is this step that thwarts most
labs whose primary focus is on sex differences in the brain and
therefore lacking in the skills needed to analyze and understand
the millions of reads produced in modern day sequencing
facilities. Vilain and colleagues (Ngun et al., 2014) solved the
problem nicely with the use of Reduced Representation Bisulfite
Sequencing (RRBS) which provides genome wide scanning
but is enriched for areas with high CpG content, thereby
greatly reducing the amount of sequencing required. As a result
the investigators were able to assess the methylation profile
in two brain regions (POA and striatum) of males, females
and masculinized females at two developmental time points,
as neonates and as adults. This is perhaps one of the most
comprehensive views of epigenetic sex differences in the brain to-
date. One of the most surprising discoveries was how few genes
exhibited differential methylation as neonate as opposed to the
large number that emerged in adulthood. Moreover, the impact
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 August 2015 | Volume 9 | Article 221
McCarthy and Nugent Epigenetics of brain sex differences
of neonatal testosterone endured, or was revealed, in adulthood,
and this was not dependent on adult hormonal status as the
gonads were removed at the time of sacrifice. They found over
1,000 genes that were differentially methylated in the striatum
of males and females, and over 600 in the adult POA. The
delayed emergence in gene methylation differences following
neonatal testosterone is a surprising and currently unexplained
observation. In contrast to the hundreds of genes that differed in
adult brain, the number of sex differential genes in the neonate
was closer to 50. Why there is such a divergence in the sex-
typic expression profiles between neonates and adults and how
the effect of testosterone on gene methylation is delayed until
adulthood and maintained independent of circulating hormones
is a fascinating and currently unresolved mystery. No doubt the
authors will continue to mine this rich database and reveal even
more surprises.
DNA Methylation Represses
Masculinization of the POA and
Reproductive Behavior
Similar to the discovery based approaches described above,
we also took a ‘‘big picture’’ view of the epigenome and
sexual differentiation by quantifying the overall level of DNA
methylation in the POA of male, female and masculinized female
rat pups (Nugent et al., 2015).We found females had significantly
higher overall DNA methylation compared to either males
or masculinized females. Whole-genome-bisulfite-sequencing
(WGBS) revealed this was due to more highly methylated CpG
sites in females and that most of this was not in CpG islands or
gene promoters but was instead in the intergenic regions, where
most DNA methylation is found. Moreover, the sex difference
in methylation was broadly distributed across the chromosomes
(Figure 3). In order to establish if the sex difference in DNA
methylation was functionally important we used two approaches.
First was to determine if reducing the DNA methylation in
females during the critical window would masculinize the POA
and adult reproductive behavior, and the second was to identify
what genes were being repressed in females as a result of elevated
DNA methylation. Both aims were achieved with the use of
DNMT inhibitors, specifically zebularine and RG108, which have
slightly different mechanisms but are similar in that they block
all DNMT activity and result in de-methylation of the DNA
(Yoo et al., 2004). After confirming this was also true in the
developing POA, newborn males and females were treated with
either RG108 or zebularine, raised to adulthood and tested for
male sexual behavior by being placed with a sexually receptive
females (all test subjects also underwent gonadectomy and
testosterone replacement to both simulate adult male circulating
hormone levels and equalize hormone levels across animals).
Both the brain and behavior of females treated with DNMT
inhibitor as neonates were fully masculinized in adulthood,
meaning they exhibited a male-like synaptic pattern and showed
normal male sexual behavior (Figure 4). This was not true of
females treated with vehicle as neonates, they showed very little
male-like behavior despite having equal circulating testosterone
levels as the time of testing as the other animals. Thus the
FIGURE 3 | CpG methylation is modulated by hormones. Cytosines are
methylated at the 5′ carbon by a class of enzymes called DNA Methyl
Transferases (DNMTs). The number of fully methylated CpGs was quantified in
DNA extracted from the preoptic area (POA) of 3 newborn females and 3
females treated with a masculinizing dose of estradiol for the previous 2 days.
Estradiol treatment significantly reduced the number of fully methylated sites
and analyses of where in the genome these sex differences reside indicated
they are predominantly in the intragenic region, where DNA methylation is
highest.
demethylation that had occurred some 60 days prior resulted
in a gene expression pattern that masculinized the brain. What
those genes might be was assessed by conducting RNA-Seq on
mRNA from the POA of males and females with and without
DNMT inhibitor treatment. To our surprise the number of genes
expressed at significantly different levels in male and female POA
was relatively small, ∼70, but consistent with the low number
observed by Vilain and colleagues using RRBS (Ghahramani
et al., 2014). About half of the genes were expressed at higher
levels in males and half at higher levels in females. Candidate
genes for masculinization are those that increased in females
following DNMT inhibition and were also higher in control
males than females. Of the 34 genes expressed at higher levels
in males, 25 of them increased in females treated with a DNMT
inhibitor (Nugent et al., 2015). It is logical to predict that in
females these genes would have increased DNA methylation in
the promoter region compared to males or masculinized females,
but exhaustive sequencing analysis found no evidence that was
the case, suggesting the change in expression of these genes was
secondary to other events or are located outside of promoters.
DNA Methylation Closes the Sensitive
Window for Sexual Differentiation
The end of the sensitive period for sexual differentiation is
defined as the developmental age at which exogenous hormone
treatment is no longer capable of masculinizing females. But why
females lose sensitivity to themasculinizing effects of steroids was
unknown. We mapped the level of DNMT activity in the POA of
males and females from birth to 2 weeks of age and determined
that females had significantly higher enzymatic activity during
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FIGURE 4 | DNA de-methylation mediates masculinization of brain and
behavior. Treatment of newborn male rat pups with DNMT inhibitors such as
Zebularine during the critical period of sexual differentiation reduces DNA
methylation and thereby changes gene expression profiles which in turn leads
to masculinization of the synaptic patterning of the POA and sexual behavior.
Thus masculization requires demethylation while feminization is a repression of
masculinization via DNA methylation.
the first few days after birth but that by 4 days of age levels
had equalized and by 1 week levels dropped precipitously in
both sexes. Thus it appears the first few days of life are highly
dynamic for DNMT activity in the POA. Further, treating
neonatal females with a masculinizing dose of estradiol reduced
DNMT activity to male-like levels, suggesting that at least one
mechanism for estradiol mediated masculinization of the POA
is via control of DNMT activity. In order to determine if DNA
methylation past the sensitive period was required to maintain
feminization of brain and behavior, we treated 10-day-old
females with DNMT inhibitor and raised them to adulthood. We
also treated some females with a masculinizing dose of estradiol
at the same time and found that as adults, these females were
not masculinized, (i.e., they were outside the sensitive period at
this time) but their littermates that had been treated with DNMT
inhibitor weremasculinized.We observed a similar phenomenon
in mice in which the DNMT3a gene was conditionally ablated
in the developing POA by an adeno-associated virus (AAV)-
Cre mediated knockout. All female DNMT3a floxed mice that
received AAV-Cre displayed male sexual behaviors compared to
very few control females. However, knockout did not occur until
outside the sensitive period (Figure 5). Collectively these data
indicate that the end of the sensitive period is a function of the
loss of inhibition of DNMT activity by estradiol. How this occurs,
from a mechanistic viewpoint, is unknown, as is why DNMT
activity drops so markedly at the end of the first week of life.
There is much still to be learned regarding the DNA methylome
and sexual differentiation of brain and behavior.
MicroRNAs as Epigenetic Regulators of
Brain Sex Differences
miRs are a type of non-coding RNA and now recognized
to be ubiquitous influencers of gene expression (Jia et al.,
2013). Largely by actively degrading mRNA but also via steric
FIGURE 5 | DNA methylation maintains feminization of brain and
behavior. Conditional knockout of DNMT3a in the POA of mice demonstrated
that reduced DNA methylation outside the critical period could still lead to
masculinization of behavior, while treatment with exogenous estradiol could
not. This was also found to be true in rats using DNMT inhibitors. During the
critical period estradiol reduces DNMT activity but this effect is lost outside of
the critical period. Thus the ongoing maintenance of DNA methylation appears
essential for continued feminization. These observations reveal a novel source
of plasticity in sexually dimorphic behavior.
hindrance, these small endogenously synthesized regulators can
modulate multiple genes simultaneously to dampen networks of
gene expression. Bale and colleagues surveyed 250 miRs in whole
neonatal mouse brain and found almost 2/3rds were expressed
at different levels in males and females (Morgan and Bale, 2012).
This is surprisingly high given they surveyed whole brains and
suggests there is a global regulation of gene expression that differs
by sex. Of the miRs that differed by sex, half of them were due
to gonadal steroid regulation and a third were due to bias in
the sex chromosomes. The remainder of the sex differences are
of unknown origin. The relative contribution of different cell
types, i.e., neurons vs. astrocytes vs. non-neuronal cells is entirely
unexplored and may be trivial or, may be pivotal. We have
explored miRs in the dentate gyrus of the neonatal hippocampus,
providing some regional as well as cellular specificity given the
high concentration of granule cells here, and we also found a
startling high number of them showed a difference in expression
based on sex. Of 14 miRs selected for their role in cell genesis
and neural differentiation, ten were found to be higher in females
than males (McCarthy et al., 2015). In this case, however, we
found no regulation by gonadal steroids and most of these miRs
are not associated with the X chromosome. These preliminary
findings point to possible regional differences in miR regulation
and impact, although species difference cannot be ruled out
as well since of the two studies done to-date looking for sex
differences in miRs in the brain, one was in mice (Bale) and
one was in rats (ours). This will be an exciting area for future
exploration.
Conclusion
With a solid 5 years since what could conceptually be viewed
as the beginning of the field of epigenetics of sex differences
in the brain its seems we are still at the very edge of the
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frontier. Genes known for decades to be central to the process
of differentiating male from female brains are clearly stamped
with epigenetic marks that presumably impact their role in the
process. Discovery of new gene participants has been slower to
come as we grapple with the biological challenges of cell and
regional specificity, the technical challenges of bioinformatics
and the interpretive challenges as to what do specific epigenetic
marks really tell us. Discriminating between what are genuine
epigenetic (although not heritable) modifications that will
permanently alter the trajectory and sensitivity of a particular
cellular endpoint and attendant behavioral profile from a
simple reflection of on going changes in gene expression is
an additional challenge. This last challenge is exacerbated by
the inability to assay changes in real time in order to gain
a more nuanced view of changes above the genome. This is
in marked contrast to the traditional physiological approaches
of sequential and repeated sampling of the same animal over
time so that one could, for instance, create an accurate profile
of testosterone changes over the course of a day, a month, a
year. Likewise for behavior, does sexual receptivity track with
time of day? Year? Hormonal profile? What we would like
to know as well is does the epigenetic marks on the genes
controlling sexual receptivity also change across the day, month
or year but current technology does not allow for repeated
sampling of the same individuals brain epigenome. This means
we need to think in new ways and frame our questions
differently than before in order to illuminate the powerful
role of epigenetics in controlling sex differences in brain and
behavior.
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